Navigation Links
Genetics Plays A Crucial Role In Preemies' Destructive Eye Disease

Researchers from The Yale School of Medicine have reported that genetics has a major role in influencing retinopathy of prematurity (ROP) in preemies//, a disease known to hamper the development of blood vessels in the retina and could cause blindness. This report is published in the November issue of Pediatrics.

“This is the first definitive study to show that genetic factors are a significant component of ROP, and to quantify the extent of that genetic contribution,” said lead author Vineet Bhandari, M.D., assistant professor of pediatrics at Yale School of Medicine.

ROP is most prevalent and severe in extremely low birth weight newborns with an overall incidence estimated to be as high as 68 percent among those born at less than 1,251 grams (2.75 pounds), and 93 percent in those born less than 750 grams (1.6 pounds). Despite early detection and intervention, ROP may lead to retinal detachment and blindness. In an attempt to treat ROP, researchers have sought significant factors, such as too much oxygen, that contribute to the disease. The Yale team hypothesized that there was a strong genetic connection involved in developing ROP.

They looked at contributing factors and outcomes for ROP within 200 twin pairs born at 32 weeks gestation or less. Study participants were from Yale, the Karolinska Institute in Sweden and the University of Connecticut. These 200 twin pairs had a mean gestational age and birth weight of 29 weeks and 1,332 grams (2.9 pounds), respectively.

“Our analyses showed that gestational age and duration of supplemental oxygen were the significant independent contributing factors for ROP,” said Bhandari. “Once significant non-genetic co-factors for ROP were identified, we calculated the genetic susceptibility and determined that 70 percent of the contribution to ROP was the result of genetic factors alone.”

“The magnitude to which genetic factors contribute to this major cause of infant morbi
'"/>




Page: 1 2

Related medicine news :

1. Genetics and cholesterol levels
2. Genetics helps in attacking cancer
3. Alcoholism Influenced By Both Genetics & Family Environment
4. Genetics linked to leukemia treatment success rate in children
5. Genetics Has A Major Role To Play In Body Shape.
6. Revolution in Genetics to Open Avenues for Treating Cancer
7. Faster way of producing Bird flu vaccine using Reverse Genetics
8. Genetics of Ageing with Preserved Mental Capacity.
9. Generation Scotland To Examine Relation Between Lifestyle, Genetics and Health
10. Genetics Might BE The Basis For Chronic Fatigue Syndrome
11. Personalized Genetics: Unraveling the Secret Code to Good Health.
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...hysical wounds, a new study says//. Phillip Maruch...s at Chicago in a study of laboratory mice, found ...nt, delayed the closing of wounds by more than 45 ...rtal eurekalert.org. A range of cell and genetic ...
...ven when people are not aware of their learning ex... 2005 issue of Nature. Researchers from University...he San Diego Veterans Affairs Health System had un...e animals humans could learn through habits formed...
...elp to prevent a certain type of hereditary// deaf...ssor in otolaryngology at the University of Iowa, ...tically deafened mouse interfering RNA (Ribonuclei...ene from being expressed that would otherwise caus...
...me men to help them improve their sexual performan...ics. Apparently the same patches can be used in wo...increase their sexual desire and activity. In a st... month the authors have looked at 447 women diagno...
Other Medicine News:Health News:Habit Memory May Enhance Learning In People 2Health News:Testosterone Patches Found To Increase Sexual Desire In Menopausal Women 2
(Date:10/14/2008)...TON, Oct. 14 /- Paratek Pharmaceutica...t, amadacycline, formerly PTK 0796, a,first-in-cla...te Breaker,poster presentation at the 48th Intersc...therapy (ICAAC). ICAAC will be held in Washington,...nformation on the poster session at ICAAC:, Su...
(Date:10/13/2008)...nalysis of SPIRIT II and SPIRIT III Data Confirms ...of Experiencing Death, a Heart Attack or a ...ars, WASHINGTON, Oct. 13 /...,s SPIRIT II and SPIRIT III randomized clinical,tr... Eluting Coronary Stent,System continues to delive...
(Date:10/13/2008)...nsion of Genomic DNA from Multiple Cancer Populati... Studies, ANN ARBOR, Mich., Oct. 13 /PRNewswire/ ...ment with SAIC-Frederick to amplify DNA samples fo...ics was selected to amplify and standardize total ...om cancer patients. The Rubicon,GenomePlex(TM) Who...
(Date:10/10/2008)...HINGTON and MENLO PARK, Calif., Oct. 10 /PRNewswir... announced that it plans to present,long-term foll...trials next,week at the Cardiovascular Research Fo...rdiovascular Therapeutics (TCT) meeting in Washing...e studies designed to investigate,the safety and e...
Breaking Medicine Technology:Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra Levitra and Cialis Type Tablets 2336 1TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra Levitra and Cialis Type Tablets 2336 2Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 1Lutheran Episcopal Church Presiding Bishops Urge Prayers for Peace in Sudan 21236 2Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference 5849 1Safety of Synthetic Turf Validated by NJ Test Results 21231 1Safety of Synthetic Turf Validated by NJ Test Results 21231 2Safety of Synthetic Turf Validated by NJ Test Results 21231 3
...nox Maintained Stability,Significantly Longer than...ile Comparable with Placebo , MARIETTA, Ga. and CO...cals, Inc., Wyeth Pharmaceuticals, a division of W...al study results on,bifeprunox, an investigational...ophrenia, today at the 2007 annual meeting of,the ...
...Approval of SEROQUEL XR--, WILMINGTON, Del., May 2...y announced that two analyses from a large-scale,s...(TM) (quetiapine,fumarate) Extended-Release Tablet...zophrenia in adult patients, were presented today,...Association,(APA). These analyses from the clinica...
Other Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
The Blackstone Spinal Fixation System is a sophisticated fixation system that provides an innovative solution to spinal stabilization. It combines technical advances in strength and stability with a
...is a versatile, low profile, titanium implant comp...trumentation needed for implantation. Reduction in...g concept. Monosegmental and multisegmental applic... with over 8,000 implantations. Tested in accordan...
...em is a comprehensive and versatile hook, rod and ...nd degenerative cases. Conceived with a complete u...LA/VSP Spine System employs segmental fixation and...bilize the spine. In deformity cases, the ISOLA/VS...
Transcranial and peripheral vascular doppler system.
Medicine Products: